DOI: 10.1177/26335565261441403 ISSN: 2633-5565

Exploring theoretical policy options for reducing socioeconomic inequalities in multimorbidity: A microsimulation study in England from 2019–2049

Anna Head, Max Birkett, Kate Fleming, Chris Kypridemos, Martin O’Flaherty

Background

Projections suggest that the number of adults living with multimorbidity will continue growing in the coming decades. Little is known, however, about the potential impact of prevention policies on multimorbidity.

Methods & findings

We applied a validated microsimulation model of multimorbidity accumulation to simulate theoretical scenarios of health improvement and inequality reduction in England over 30 years (2019-2049), compared to a baseline scenario of continuing patterns in accumulation. Four theoretical scenarios were based on Benach et al.’s typology of health policies: 1) targeted intervention on the worst-off; 2) universal policy + additional focus on the gap; 3) redistributive policy; 4) proportionate universalism; plus an idealistic fifth scenario completely removing socioeconomic inequality in transition times between states. We selected a target of 3% reduction in mortality for scenarios 1-4, based on reductions seen from tobacco control policies. Outputs compared were: difference in 2049 projected prevalence and numbers compared to baseline, total cases prevented/postponed compared to baseline, and expected years lived without multimorbidity at age 30. Our results suggest that gains in levelling socioeconomic inequalities in health would prevent/postpone multimorbidity cases and reduce relative health inequalities among those aged <65. However, this would also likely lead to increased absolute numbers living with multimorbidity overall.

Conclusions

Our theoretical modelling suggests effective and equitable policies have potential to reduce the population-level burden of multimorbidity, postponing a substantial number of multimorbidity cases, particularly before age 65. This is, however, likely to lead to greater absolute numbers of multimorbidity cases as individuals live for longer.

More from our Archive